rs375516507
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The ENST00000270162.8(SIK1):c.2243G>A(p.Arg748His) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R748C) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000270162.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SIK1 | NM_173354.5 | c.2243G>A | p.Arg748His | missense_variant | 14/14 | ENST00000270162.8 | NP_775490.2 | |
SIK1 | XM_011529474.3 | c.2096G>A | p.Arg699His | missense_variant | 13/13 | XP_011527776.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SIK1 | ENST00000270162.8 | c.2243G>A | p.Arg748His | missense_variant | 14/14 | 1 | NM_173354.5 | ENSP00000270162 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 526Hom.: 0 Cov.: 0 FAILED QC
GnomAD3 exomes AF: 0.0000345 AC: 8AN: 232084Hom.: 0 AF XY: 0.0000313 AC XY: 4AN XY: 127666
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000125 AC: 5AN: 39974Hom.: 1 Cov.: 0 AF XY: 0.0000984 AC XY: 2AN XY: 20332
GnomAD4 genome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 526Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 240
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 30 Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 12, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at